{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:35:45Z","timestamp":1790516145066,"version":"4.1.0"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T00:00:00Z","timestamp":1433462400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0128990","type":"journal-article","created":{"date-parts":[[2015,6,5]],"date-time":"2015-06-05T19:16:19Z","timestamp":1433531779000},"page":"e0128990","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Developing Molecular Signatures for Chronic Lymphocytic Leukemia"],"prefix":"10.1371","volume":"10","author":[{"given":"Edouard","family":"Cornet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agathe","family":"Debliquis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Rimelen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natacha","family":"Civic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myl\u00e8ne","family":"Docquier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xavier","family":"Troussard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Dr\u00e9nou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Matthes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,6,5]]},"reference":[{"key":"ref1","first-page":"1640","article-title":"The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL","volume":"8","author":"E Matutes","year":"1994","journal-title":"Leukemia"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1182\/asheducation.V2012.1.76.3806845","article-title":"Implications of new prognostic markers in chronic lymphocytic leukemia","volume":"2012","author":"N Chiorazzi","year":"2012","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1182\/blood.V94.6.1848","article-title":"Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia","volume":"94","author":"TJ Hamblin","year":"1999","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1182\/blood.V94.6.1840","article-title":"Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia","volume":"94","author":"RN Damle","year":"1999","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1056\/NEJM200012283432602","article-title":"Genomic aberrations and survival in chronic lymphocytic leukemia","volume":"343","author":"H Dohner","year":"2000","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nbt1385","article-title":"Direct multiplexed measurement of gene expression with color-coded probe pairs","volume":"26","author":"GK Geiss","year":"2008","journal-title":"Nat Biotechnol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1182\/blood-2013-06-508937","article-title":"Molecular classification of mature aggressive B-cell lymphoma using digital multiplexed gene expression on formalin-fixed paraffin-embedded biopsy specimens","volume":"122","author":"N Masque-Soler","year":"2013","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1182\/blood-2013-11-536433","article-title":"Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue","volume":"123","author":"DW Scott","year":"2014","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e49010","DOI":"10.1371\/journal.pone.0049010","article-title":"Using digital RNA counting and flow cytometry to compare mRNA with protein expression in acute leukemias","volume":"7","author":"P Fernandez","year":"2012","journal-title":"PLoS One"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1182\/blood-2007-06-093906","article-title":"Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines","volume":"111","author":"M Hallek","year":"2008","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1172\/JCI3009","article-title":"Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors","volume":"102","author":"F Fais","year":"1998","journal-title":"J Clin Invest"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1038\/sj.leu.2403202","article-title":"Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 Concerted Action BMH4-CT98-3936","volume":"17","author":"JJ van Dongen","year":"2003","journal-title":"Leukemia"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.leu.2404457","article-title":"ERIC recommendations on IGHV gene mutational status analysis in chronic lymphocytic leukemia","volume":"21","author":"P Ghia","year":"2007","journal-title":"Leukemia"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.mimet.2010.12.025","article-title":"Orientation and expression of methicillin-resistant Staphylococcus aureus small RNAs by direct multiplexed measurements using the nCounter of NanoString technology","volume":"84","author":"M Beaume","year":"2011","journal-title":"J Microbiol Methods"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"RESEARCH0034","DOI":"10.1186\/gb-2002-3-7-research0034","article-title":"Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes","volume":"3","author":"J Vandesompele","year":"2002","journal-title":"Genome Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1056\/NEJMoa023143","article-title":"ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia","volume":"348","author":"M Crespo","year":"2003","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1182\/blood-2007-05-092882","article-title":"Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia","volume":"112","author":"LZ Rassenti","year":"2008","journal-title":"Blood"},{"key":"ref18","first-page":"56","article-title":"The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia","volume":"91","author":"MB van't Veer","year":"2006","journal-title":"Haematologica"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3324\/haematol.2009.010298","article-title":"Gene expression factors as predictors of genetic risk and survival in chronic lymphocytic leukemia","volume":"95","author":"D Kienle","year":"2010","journal-title":"Haematologica"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3333","DOI":"10.1182\/blood-2003-05-1585","article-title":"Activation-induced cytidine deaminase in chronic lymphocytic leukemia B cells: expression as multiple forms in a dynamic, variably sized fraction of the clone","volume":"102","author":"E Albesiano","year":"2003","journal-title":"Blood"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"4903","DOI":"10.1182\/blood-2002-09-2906","article-title":"High expression of activation-induced cytidine deaminase (AID) and splice variants is a distinctive feature of poor-prognosis chronic lymphocytic leukemia","volume":"101","author":"H McCarthy","year":"2003","journal-title":"Blood"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"4076","DOI":"10.1182\/blood-2010-09-304881","article-title":"LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts overall survival in untreated patients","volume":"117","author":"H Duzkale","year":"2011","journal-title":"Blood"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"3937","DOI":"10.1200\/JCO.2004.12.133","article-title":"Microarray gene expression profiling of B-cell chronic lymphocytic leukemia subgroups defined by genomic aberrations and VH mutation status","volume":"22","author":"C Haslinger","year":"2004","journal-title":"J Clin Oncol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1182\/blood-2004-08-3344","article-title":"The LPL\/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia","volume":"106","author":"P Oppezzo","year":"2005","journal-title":"Blood"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1038\/sj.leu.2403748","article-title":"High expression of lipoprotein lipase in poor risk B-cell chronic lymphocytic leukemia","volume":"19","author":"D Heintel","year":"2005","journal-title":"Leukemia"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.leukres.2013.02.008","article-title":"Lipoprotein lipase in chronic lymphocytic leukaemia\u2014strong biomarker with lack of functional significance","volume":"37","author":"E Porpaczy","year":"2013","journal-title":"Leuk Res"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Patricia Weiss EAP, Trang Le, Cathrin Skrabs, Michaela Gruber, Clemens Pausz, Ulrich J\u00e4ger and Katrina Vanura (2012) Cannabinoid Receptor 1 in Chronic Lymphocytic Leukemia: Strong Prognostic Marker with Limited Therapeutic Use. ASH Abstract Book.","DOI":"10.1182\/blood.V120.21.4565.4565"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"e34347","DOI":"10.1371\/journal.pone.0034347","article-title":"Epigenetic silencing of the circadian clock gene CRY1 is associated with an indolent clinical course in chronic lymphocytic leukemia","volume":"7","author":"M Hanoun","year":"2012","journal-title":"PLoS One"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/j.1600-0609.2009.01287.x","article-title":"Combined PER2 and CRY1 expression predicts outcome in chronic lymphocytic leukemia","volume":"83","author":"L Eisele","year":"2009","journal-title":"Eur J Haematol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1182\/blood-2007-05-092486","article-title":"Relevance of CD49d protein expression as overall survival and progressive disease prognosticator in chronic lymphocytic leukemia","volume":"111","author":"V Gattei","year":"2008","journal-title":"Blood"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/hon.888","article-title":"CD26 expression in mature B-cell neoplasia: its possible role as a new prognostic marker in B-CLL","volume":"27","author":"L Cro","year":"2009","journal-title":"Hematol Oncol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4161\/cbt.10.2.12168","article-title":"Expression and prognostic assessment of dipeptidyl peptidase IV and related enzymes in B-cell chronic lymphocytic leukemia","volume":"10","author":"ML Sulda","year":"2010","journal-title":"Cancer Biol Ther"},{"key":"ref33","first-page":"346","article-title":"Identification of a global gene expression signature of B-chronic lymphocytic leukemia","volume":"1","author":"DF Jelinek","year":"2003","journal-title":"Mol Cancer Res"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"e28277","DOI":"10.1371\/journal.pone.0028277","article-title":"A two-gene signature, SKI and SLAMF1, predicts time-to-treatment in previously untreated patients with chronic lymphocytic leukemia","volume":"6","author":"CD Schweighofer","year":"2011","journal-title":"PLoS One"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Cinzia Bologna RB, Sara Serra, Tiziana Vaisitti, Valentina Audrito, Davide Brusa Davide Rossi, Marta Coscia, Gianluca Gaidano, Cox Terhorst, and Silvia Deaglio (2012) SLAMF1\/CD150 is a signaling receptor in a subset of chronic lymphocytic leukemia cells. The Journal of Immunology.","DOI":"10.4049\/jimmunol.188.Supp.46.9"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1182\/blood-2008-01-131359","article-title":"FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia","volume":"112","author":"FJ Li","year":"2008","journal-title":"Blood"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"e39902","DOI":"10.1371\/journal.pone.0039902","article-title":"HS1, a Lyn kinase substrate, is abnormally expressed in B-chronic lymphocytic leukemia and correlates with response to fludarabine-based regimen","volume":"7","author":"F Frezzato","year":"2012","journal-title":"PLoS One"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s00277-009-0742-6","article-title":"IGHV gene mutational status and LPL\/ADAM29 gene expression as clinical outcome predictors in CLL patients in remission following treatment with oral fludarabine plus cyclophosphamide","volume":"88","author":"K Maloum","year":"2009","journal-title":"Ann Hematol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"4944","DOI":"10.1182\/blood-2002-10-3306","article-title":"ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile","volume":"101","author":"A Wiestner","year":"2003","journal-title":"Blood"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/cyto.b.20132","article-title":"Evaluation of ZAP-70 expression by flow cytometry in chronic lymphocytic leukemia: A multicentric international harmonization process","volume":"70","author":"R Letestu","year":"2006","journal-title":"Cytometry B Clin Cytom"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/cyto.b.21132","article-title":"ZAP70 in B-CLL cells related to the expression in NK cells is a surrogate marker for mutational status","volume":"86","author":"TG Wiggers","year":"2014","journal-title":"Cytometry B Clin Cytom"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1101\/gr.152132.112","article-title":"Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia","volume":"24","author":"PG Ferreira","year":"2014","journal-title":"Genome Res"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3324\/haematol.2014.109777","article-title":"Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting","volume":"100","author":"LA Sutton","year":"2015","journal-title":"Haematologica"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1182\/blood-2012-05-429282","article-title":"The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial","volume":"121","author":"DG Oscier","year":"2013","journal-title":"Blood"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1182\/blood-2014-01-546150","article-title":"Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial","volume":"123","author":"S Stilgenbauer","year":"2014","journal-title":"Blood"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0128990","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T04:58:13Z","timestamp":1691729893000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0128990"}},"subtitle":[],"editor":[{"given":"Michael","family":"Baudis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,6,5]]},"references-count":45,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2015,6,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0128990","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,6,5]]}}}